The company issued revenue guidance of $106 million-$115 million, compared to the consensus revenue estimate of $105.65 million. This compares to break-even earnings per share a year ago. BLFS earnings call for the period ending March 31, 2021. Equities analysts expect that BioLife Solutions, Inc. (NASDAQ:BLFS) will announce $28.71 million in sales for the current fiscal quarter, Zacks reports. We also note that HRC has a PEG ratio of 2.54. This quarterly report represents an earnings … 5 Stocks Under $10 That Are Poised to Take Off Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! BioLife Solutions, Inc. (BLFS) came out with a quarterly loss of $0.06 per share in line with the Zacks Consensus Estimate. Stocks with single-digit growth estimates will have a higher rating than others, as our research has shown that well-established dividend-paying companies have modest earnings growth estimates. For the financial year, BioLife Solutions Inc. [NASDAQ:BLFS] is expected to bring in … ... Ocugen is expected to report Q1 earnings on Friday, May 7. This compares to earnings … Earnings estimates and surprises for Biolife Solutions (BLFS) are an important tool used to evaluate the company's overall strength and value of the stock. BioLife Solutions, Inc. (NASDAQ:BLFS) investors will be delighted, with the company turning in some strong numbers with its latest results.Revenues and losses per share were both better than expected, with revenues of US$17m leading estimates by 4.2%. 12:40AM. The company said it expects 2021 revenue of $106.0 million to $115.0 million. Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Brokerages predict that BioLife Solutions, Inc. (NASDAQ:BLFS) will report earnings per share (EPS) of ($0.05) for the current quarter, Zacks Investment Research reports. BLFS currently has a PEG ratio of 52.47. BioLife Solutions, Inc. (BLFS) delivered earnings and revenue surprises of 40.00% and 8.01%, respectively, for the quarter ended March 2021. This compares to break-even earnings per share a year ago. BLFS Earnings Estimates For The Current Year. This information can give you a slight idea of what you might expect for the next quarter's release. The medical equipment provider reported ($0.03) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.02). By Rosalind Gate June 18, 2021 How have the shares performed? What Do Analysts Say About BioLife Solutions Inc. (BLFS)? This suggests that analysts have very recently bumped up their estimates for BLFS, giving the stock a Zacks Earnings ESP of +11.11% heading into earnings … Biolife Solutions Inc (BLFS) Q1 2021 Earnings Call Transcript May. These figures are adjusted for non-recurring items. Wall Street expects an EPS loss of $0.04 and sales around $16.05 million. The medical equipment provider reported ($0.03) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.02). The company provided earnings per share (EPS) guidance of – for the period. Barron's also provides information on historical stock ratings, target prices, company earnings… BioLife (BLFS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. View real-time stock prices and stock quotes for a full financial overview. Earnings Estimate. PR Newswire. This suggests that analysts have very recently bumped up their estimates for BLFS, giving the stock a Zacks Earnings ESP of +11.11% heading into earnings … 14, 2021 at 12:30 a.m. BioLife Solutions, Inc. is estimated to report earnings on 08/05/2021. The following information was filed by Biolife Solutions Inc (BLFS) on Monday, March 22, 2021 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. The company also raised its FY21 EPS and sales guidance above analyst estimates. NASDAQ:BLFS traded up $0.06 on Friday, reaching $33.31. BLFS updated stock price target summary. BioLife Solutions had a negative return on equity of 0.35% and a negative net margin of 39.34%. Growth Estimates BLFS IND S&P; Current Qtr (06/2021) 92.86: 425.37: 146.15: Next Qtr (09/2021) 25.00: 44.82: ... By taking the current earnings estimate and dividing it by the estimate … BioLife Solutions, Inc. (BLFS) consensus earnings estimates: forecast for revenue and EPS, high & low, YoY growth, forward PE and number of analysts. So we estimate that a normalized year-over-year growth rate for media this quarter was approximately 25%. ET on Motley Fool BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Tops Revenue Estimates Below you can see how BLFS performed 4 days prior and 4 days after releasing the earnings report. In fact, the Most Accurate Estimate for the current quarter is currently at a loss of 4 cents per share for BLFS, compared to a broader Zacks Consensus Estimate of a loss of 5 cents per share. Get prepared with the key expectations. ... the Alliance for Regenerative Medicine or ARM estimates there are nearly … In fact, the Most Accurate Estimate for the current quarter is currently at 4 cents per share for BLFS, compared to a broader Zacks Consensus Estimate of a break even earnings. BOTHELL, Wash., March 22, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced financial results for the fourth quarter and year ended December 31, 2020. BOTHELL, Wash., March 22, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced financial results for the fourth quarter and year ended December 31, 2020. Biolife Solutions (BLFS) reported 1st Quarter March 2021 earnings of $0.01 per share on revenue of $16.8 million. BioLife Solutions (NASDAQ:BLFS) last posted its earnings results on Wednesday, May 12th. Edited Transcript of BLFS.OQ earnings conference call or presentation 14-May-20 8:30pm GMT. So we estimate that a normalized year-over-year growth rate for media this quarter was approximately 25%. Statutory losses were smaller than the analystsexpected, coming in at US$0.03 per share. Biolife Solutions 's earnings in 2021 is -$20,286,000.On average, 3 Wall Street analysts forecast BLFS's earnings for 2021 to be $4,713,533, with the lowest BLFS earnings forecast at $2,019,509, and the highest BLFS earnings forecast at $9,289,740. BioLife (BLFS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. BioLife Solutions posted earnings of ($0.70) per share during the same quarter […] BioLife Solutions (NASDAQ:BLFS) issued an update on its FY 2021 earnings guidance on Thursday morning. Ballard ... BLFS… These figures are adjusted for non-recurring items. BioLife Solutions, Inc. (BLFS) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.05. Revenue grew 38.5% on a year-over-year basis. BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Tops Revenue Estimates Zacks - Thu May 13, 5:05PM CDT Zacks Equity Research - ZACKS - Thu May 13, 5:05PM CDT BioLife Solutions, Inc. (BLFS) delivered earnings and revenue surprises of 40.00% and … Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The […] Get prepared with the key expectations. 07:40AM. Q1 2019 (Mar 2019) EPS of $0.02 missed by -$0.01 Revenue of $5.77M (51.25% YoY) missed by -$0.21M. BLFS's fiscal year ends in December. BioLife Solutions (BLFS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. Highest estimate $0.31 Mean estimate $0.19 Lowest estimate $0.13. Upgrade to Premium to get unlimited access to Ratings, Recommendations, Payout Estimates, and … The Whisper Report – a weekly newsletter discussing the current trading environment and upcoming earnings releases. These figures are adjusted for non-recurring items. The consensus estimate was a loss of $0.01 per share on revenue of $16.1 million. BioLife Solutions (NASDAQ:BLFS) announces its next round of earnings this Thursday, May 13.Here is Benzinga's everything-that-matters guide for this Thursday's Q1 earnings announcement. What Are Analyst Estimates and Earnings Surprises, and Why Do They Matter? BioLife Solutions Inc. analyst ratings, historical stock prices, earnings estimates & actuals. When assessing earnings from the past eight quarters, Biolife Solutions Inc has a trend of missing estimates. The estimates represent upside of 48.20% and -52.63% in the company’s revenue and earnings per share, respectively, on a year-on-year basis. BioLife Solutions Announces $9.6 Million to $9.8 Million in Preliminary Revenue for Q2 2020. Thomson Reuters StreetEvents. BioLife Solutions, Inc. (BLFS) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.05. BIOL | Complete Biolase Inc. stock news by MarketWatch. Wall Street analysts are predicting $-0.02 earnings per share this time around, which is 50.0% higher than the $-0.04 per share realized in Q3 2020. This figure is similar to the commonly-used P/E ratio, with the PEG ratio also factoring in a company's expected earnings growth rate. The lowest EPS estimate is ($0.06) and the highest is ($0.03). This compares to earnings of $0.06 per share a year ago. BioLife Solutions earnings in the same period a year ago was $0.06 per … Your browser of choice has not been tested for use with Barchart.com. BioLife Solutions had a negative net margin of 39.34% and a negative return on equity of 0.35%. View today's stock price, news and analysis for BioLife Solutions Inc. (BLFS). Annual Consensus Estimates and Ranges. Also, you can see the pre-estimates and the actual earnings. Aurora Cannabis Inc. (ACB) Reports Q3 Loss, Misses Revenue Estimates Aurora Cannabis Inc. (ACB) delivered earnings and revenue surprises of -41.18% and … Latest Earnings Estimate Range. A list of all daily earnings releases, including the Earnings Whisper Grades used to measure the likelihood of a Post-Earnings Announcement Drift. HRC currently has a forward P/E ratio of 18.45, while BLFS has a forward P/E of 524.75. Duration of the delay for other exchanges varies. This suggests that analysts have very recently bumped up their estimates for BLFS, giving the stock a Zacks Earnings ESP of +816.68% heading into earnings season. Four analysts have provided estimates for BioLife Solutions' earnings. The lowest sales estimate is $25.50 million and the highest is … Emailed alerts for those stocks reporting results with an A+ Earnings Whisper Grade. Four analysts have made estimates for BioLife Solutions’ earnings. BLFS earnings call for the period ending December 31, 2019. BioLife Solutions (NASDAQ:BLFS) last announced its quarterly earnings data on Wednesday, May 12th. A high-level overview of Senseonics Holdings, Inc. (SENS) stock. BioLife Solutions, Inc. (BLFS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Previous. BioLife Solutions, Inc. (BLFS Quick Quote BLFS - Free Report) came out with a quarterly loss of $0.06 per share in line with the Zacks Consensus Estimate. Jul-01-20 04:02PM. BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Tops Revenue Estimates. BLFS earnings call for the period ending March 31, 2021. BioLife Solutions Announces Pricing of $75 Million Public Offering of Common Stock.
Cylinder Surface Area Calculator, Wittenberg Baseball Coaches, London Classic Car Show 2019, Hipster Quiz Buzzfeed, Head Heavy Tennis Rackets, Wiring Foundationless Frames, Dummy Deadbolt Cover Plate Black, Supreme Court Judges Australia,